← Dassault Systemes overview

Dassault Systemes vs PTC: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Dassault Systemes SE (DSY.PA)

Q3 2026
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

August 2026
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

Latest
▲4

Dassault expands life-sciences AI with ArisGlobal deal and new AI tools

  • ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

    This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

  • Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

    Solid results and confirmed guidance underpin investor confidence in the company's core business.

  • New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

    Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

  • Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

    A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

PTC Inc (PTC)

Q3 2026
▲3▼1

Schneider's $22.6B cash buyout of PTC drives the stock

  • Schneider agrees to buy PTC for $205/share in cash Schneider Electric agreed to acquire PTC for $205 per share in cash, about $22.6 billion, a 42% premium to the prior close. PTC shares jumped roughly 34-36% pre-market. The deal is expected to close by Q3 2027, pending approvals.

    This is the single biggest force moving PTC now, setting a floor near the offer price.

  • Takeover premium and cash offer limit downside Because the offer is all cash at a fixed $205, PTC's price is now tied to deal-completion odds rather than earnings. If the deal closes, holders get $205; if it breaks, the stock could fall back toward where it traded before the bid.

    Explains why the stock moves on deal news, not company results, and what the main risk is.

  • Weak Q3 results and falling profit before the bid PTC's Q3 earnings and revenue fell from a year earlier, with revenue down 6.8% to $600 million. Analysts also expected earnings to decline about 13.8% a year for three years, as heavy AI and cloud spending weighed on profit.

    Shows the weak business backdrop that made PTC a takeover target and would matter if the deal fails.

  • AI product push with NVIDIA and Onshape Labs PTC launched Onshape Labs, an early-access program for AI tools in its cloud CAD platform, and is integrating NVIDIA's Omniverse libraries into its 3D apps. These support future growth but cost money now and may not quickly lift profit.

    Shows the technology story behind PTC's value, though it is secondary to the buyout now.

August 2026
▲3▼1

Schneider's $22.6B cash buyout of PTC drives the stock

  • Schneider agrees to buy PTC for $205/share in cash Schneider Electric agreed to acquire PTC for $205 per share in cash, about $22.6 billion, a 42% premium to the prior close. PTC shares jumped roughly 34-36% pre-market. The deal is expected to close by Q3 2027, pending approvals.

    This is the single biggest force moving PTC now, setting a floor near the offer price.

  • Takeover premium and cash offer limit downside Because the offer is all cash at a fixed $205, PTC's price is now tied to deal-completion odds rather than earnings. If the deal closes, holders get $205; if it breaks, the stock could fall back toward where it traded before the bid.

    Explains why the stock moves on deal news, not company results, and what the main risk is.

  • Weak Q3 results and falling profit before the bid PTC's Q3 earnings and revenue fell from a year earlier, with revenue down 6.8% to $600 million. Analysts also expected earnings to decline about 13.8% a year for three years, as heavy AI and cloud spending weighed on profit.

    Shows the weak business backdrop that made PTC a takeover target and would matter if the deal fails.

  • AI product push with NVIDIA and Onshape Labs PTC launched Onshape Labs, an early-access program for AI tools in its cloud CAD platform, and is integrating NVIDIA's Omniverse libraries into its 3D apps. These support future growth but cost money now and may not quickly lift profit.

    Shows the technology story behind PTC's value, though it is secondary to the buyout now.

Latest
▲3▼1

Schneider's $22.6B cash buyout of PTC drives the stock

  • Schneider agrees to buy PTC for $205/share in cash Schneider Electric agreed to acquire PTC for $205 per share in cash, about $22.6 billion, a 42% premium to the prior close. PTC shares jumped roughly 34-36% pre-market. The deal is expected to close by Q3 2027, pending approvals.

    This is the single biggest force moving PTC now, setting a floor near the offer price.

  • Takeover premium and cash offer limit downside Because the offer is all cash at a fixed $205, PTC's price is now tied to deal-completion odds rather than earnings. If the deal closes, holders get $205; if it breaks, the stock could fall back toward where it traded before the bid.

    Explains why the stock moves on deal news, not company results, and what the main risk is.

  • Weak Q3 results and falling profit before the bid PTC's Q3 earnings and revenue fell from a year earlier, with revenue down 6.8% to $600 million. Analysts also expected earnings to decline about 13.8% a year for three years, as heavy AI and cloud spending weighed on profit.

    Shows the weak business backdrop that made PTC a takeover target and would matter if the deal fails.

  • AI product push with NVIDIA and Onshape Labs PTC launched Onshape Labs, an early-access program for AI tools in its cloud CAD platform, and is integrating NVIDIA's Omniverse libraries into its 3D apps. These support future growth but cost money now and may not quickly lift profit.

    Shows the technology story behind PTC's value, though it is secondary to the buyout now.

© 2026 MarketIVWhy